MEDSIR participated in the IST INNOVATION FORUM · GU event in Guildford, bringing together leading experts to discuss innovation and emerging developments in genitourinary cancers.
Public source
Publisher name
Public post
📣 Today is the day! The IST INNOVATION FORUM · GU takes place today in Guildford, bringing together leading experts to discuss innovation and emerging developments in g…
Company
MEDSIR
Bring Your Idea To Life 💡
- Industry
- Research Services
- Location
- Barcelona, ES
- Company size
- 51–200 employees
About MEDSIR
MEDSIR is an international private company that was founded by scientific experts in oncology back in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from the initial study conception to the final publication of results. We act as the link between our international network of brilliant oncology investigators and the parties (Pharma Companies, Biotechs, Public Institutions, etc.) interested in providing the funding for their clinical research ideas. We help transform the most promising concepts from all around the world into strategic clinical trials that promote patient benefit, scientific advancement, and efficient drug development. Today we support more than 200 ideas involving the most innovative drugs on the market and in development, optimizing every step of investigator-initiated research. Our international team of high-level clinicians and research experts are passionate about collaborating with top medical oncologists and pharmaceutical companies in order to help them develop the best treatments for patients as quickly as possible. Want to know more about us? Feel free to visit our website: www.medsir.org Work with us & Bring your idea to life! #WeAreMEDSIR At MEDSIR we have carried out the adaptation to the General Data Protection Regulation. Before following our profile, please consult our Privacy Policy available at https://medsir.org/privacy-policy/
See moreLatest activity
Latest activity from MEDSIR
5 signals
Research & Knowledge
MEDSIR published a new edition of its newsletter featuring highlights from the summer and upcoming events, initiatives, and opportunities to connect.
Research & Knowledge
MEDSIR announced the enrollment of the first patient in the BEXAR investigator-initiated trial led by Dr. César Serrano at the Vall d'Hebron Institute of Oncology in collaboration with Faron and GEIS.
Presence & Recognition
MEDSIR participated in the IST Innovation Forum - GU 2026 in Guildford, bringing together an international community of emerging and established experts.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Cancer Grand Challenges
Cancer Grand Challenges Conference Day two featured Spatial biology discussions with attendees exchanging ideas and exploring advances.
Presence & Recognition
Cancer Research UK Manchester Institute
Cancer Research UK Manchester Institute is attending the Cancer Research UK Lung Cancer Centre of Excellence Conference in Manchester from November 3 to 6, 2026, featuring three Institute Group Leaders discussing lung cancer research.
Presence & Recognition
CancerTools.org
CancerTools.org is participating in the Cancer Research Horizons conference at booth C25, alongside Cancer Research Horizons.
Presence & Recognition
Instem
Instem is exhibiting at the 14th International Conference on Environmental Mutagens (ICEM 2026) at the Edinburgh International Conference Centre from 6 to 10 September.
Presence & Recognition
FutureMeds